| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |